Survodutide, single vial

Dual glucagon/GLP-1 receptor agonist

Survodutide

Dual glucagon/GLP-1 receptor agonist. Supplied for laboratory research use only.

  • Dual glucagon/GLP-1 agonist; Phase 3 SYNCHRONIZE and LIVERAGE programmes
  • SYNCHRONIZE-1 published in the New England Journal of Medicine, 76 weeks
  • Not approved anywhere; holds FDA Fast Track and Breakthrough status
  • Supplied for laboratory research use only. Not for human or veterinary use.
$239.99$359.97 Save 33%
Choose your supply
Most Popular
Best Value
In stock, ready to ship

90-Day Money-Back Guarantee

Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.

Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.

What it is
CompoundSurvodutide, also designated BI 456906
ClassDual glucagon/GLP-1 receptor agonist
FormLyophilised powder, supplied in a vial
OriginatorBoehringer Ingelheim, licensed from Zealand Pharma
Development status

Survodutide is an investigational compound and is not approved by the FDA for any indication. It is in Phase 3 clinical trials under the SYNCHRONIZE and LIVERAGE programmes.

Not approved anywhere; investigational. FDA has granted Fast Track and Breakthrough Therapy designations for MASH with fibrosis. A designation is not an approval.

Shipping & returns
ReturnsNinety days from delivery. Contact us and we will refund the purchase price.
Survodutide $239.99

The specifics

The details, if you want them.

DeveloperBoehringer Ingelheim (licensed from Zealand Pharma)
ClassDual glucagon/GLP-1 receptor agonist
Amino acids29
Trial phasePhase 3
FormLyophilised powder
Receptor target(s)glucagon receptor, GLP-1 receptor
Binding mechanismC18 fatty diacid conjugated via a glycine-serine linker at position 24, enabling albumin binding; supports once-weekly dosing

Development

Where it is up to.

In Phase 3 development (SYNCHRONIZE and LIVERAGE trials). Holds FDA Fast Track and Breakthrough Therapy designations for one indication — designations, not approvals.

Questions

The questions people actually ask.

What is survodutide?
A synthetic peptide developed by Boehringer Ingelheim that acts on the glucagon and GLP-1 receptors.
Is survodutide approved by the FDA?
No. It is not approved by the FDA, EMA, MHRA, or TGA for any use. It's in Phase 3 trials and holds FDA Fast Track/Breakthrough designations for one indication — not approvals.
What does "Research Use Only" mean?
Research Use Only means exactly that: intended for laboratory and research settings only, not for human or animal use, consumption, diagnosis, treatment, cure, or prevention of any disease.
How is survodutide supplied?
As a vial of lyophilised (freeze-dried) powder, sold for laboratory and research use only.
What is your refund policy?
Ninety days from delivery. If you decide against it inside that window, contact hello@getmrpeps.com and we will refund the purchase price. Damaged or incorrect orders are replaced or refunded regardless.